![Malte Greune](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malte Greune
Direttore operativo presso
CUREVAC
Profilo
Malte Greune occupa la posizione di Chief Operating & Production Officer presso CureVac NV. In passato ha ricoperto la posizione di VP-Cartucce, Dispositivi & Gruppo Tecnologico Insulina presso Sanofi-Aventis Deutschland GmbH. Ha ricevuto un dottorato dalla Universitt zu Kln, una laurea presso l'Universität Trier e un MBA presso la Clark University.
Posizioni attive di Malte Greune
| Società | Posizione | Inizio |
|---|---|---|
| CUREVAC | Direttore operativo | 01/07/2021 |
Precedenti posizioni note di Malte Greune
| Società | Posizione | Fine |
|---|---|---|
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Corporate Officer/Principal | - |
Formazione di Malte Greune
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
2
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Clark University
 Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Trier
 University of Trier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
